CD8A and neoplasm: In other studies, instead, tumor-associated CD103+ CD8 TRM showed regulatory properties (CTLA-4 and IL-10 expression), and were found to adopt a dysfunctional phenotype over time by expressing the highest levels of PD-1, TIM-3, CTLA-4, and LAG-3 (74).